Year archive

BIOTRON LIMITED — 2017 filings

All 37 regulatory filings released by BIOTRON LIMITED (BIT) in 2017, sourced directly from the official regulator.

37 Filings

2017 Period

2017 filings (37)

Filing	Released	Lang
Appendix 3B 9 pages 95.1KB Regulatory Filings	2017-12-07	English
Resignation of a Director 3 pages 37.3KB Regulatory Filings	2017-11-19	English
AGM Presentation 19 pages 1.7MB Regulatory Filings	2017-11-19	English
Results of Meeting 2 pages 38.8KB Regulatory Filings	2017-11-19	English
Biotron Compounds Demonstrate Activity Against HBV 2 pages 43.3KB Regulatory Filings	2017-11-14	English
$1.6 Million R&D Tax Incentive Received 1 page 37.6 Regulatory Filings	2017-10-31	English
Response to ASX Price Query 5 pages 186.8KB Regulatory Filings	2017-10-25	English
Annual Report and Notice of AGM/Proxy Form 55 pages 2.0MB Regulatory Filings	2017-10-17	English
Appendix 4C - quarterly 5 pages 166.0KB Regulatory Filings	2017-10-12	English
Presentation to Investors 15 pages 3.1MB Regulatory Filings	2017-10-05	English
Appendix 4G and Corporate Governance Statement 20 pages 201.6KB Regulatory Filings	2017-08-27	English
Full Year Statutory Accounts 53 pages 586.4KB Regulatory Filings	2017-08-27	English
BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited 2 pages 38.7KB Regulatory Filings	2017-07-26	English
Appendix 3B 9 pages 95.1KB Regulatory Filings	2017-07-18	English
Appendix 4C - quarterly 5 pages 91.1KB Regulatory Filings	2017-07-12	English
Change of Director's Interest Notice 3 pages 83.3KB Regulatory Filings	2017-07-04	English
Change of Director's Interest Notices 11 pages 109.5KB Regulatory Filings	2017-06-27	English
Change of Director's Interest Notice 3 pages 83.1KB Regulatory Filings	2017-06-26	English
New Issue Oversubscribed 1 page 33.1KB Regulatory Filings	2017-06-22	English
Change of Director's Interest Notice 3 pages 83.0KB Regulatory Filings	2017-06-21	English
Change of Director's Interest Notice 3 pages 47.5KB Regulatory Filings	2017-06-18	English
BIT225 Phase 2 HIV-1 Clinical Trial Update 2 pages 48.1KB Regulatory Filings	2017-06-14	English
Advisor appointed to advance commercialisation in China 2 pages 38.4KB Regulatory Filings	2017-06-08	English
Appendix 3B 14 pages 127.0KB Regulatory Filings	2017-05-24	English
Renounceable Issue 23 pages 2.1MB Regulatory Filings	2017-05-24	English
Prospectus 41 pages 175.3KB Regulatory Filings	2017-05-24	English
The Need for Drugs Targeting HIV-1 in Macophages 2 pages 67.1KB Regulatory Filings	2017-04-30	English
Appendix 4C - quarterly 5 pages 90.9KB Regulatory Filings	2017-04-19	English
Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial 2 pages 42.4KB Regulatory Filings	2017-04-10	English
Letter to Shareholders 3 pages 237.1KB Regulatory Filings	2017-02-26	English
Half Yearly Report and Accounts 19 pages 257.2KB Regulatory Filings	2017-02-23	English
Commencement of BIT225 Phase 2 HIV-1 Clinical Trial 2 pages 44.3KB Regulatory Filings	2017-02-12	English
$1.6 Million R&D Tax Rebate Received 1 page 34.6KB Regulatory Filings	2017-02-12	English
BIT225 Accelerates HIV-1 Virus Reduction 2 pages 38.3KB Regulatory Filings	2017-02-05	English
Appendix 4C - quarterly 5 pages 85.6KB Regulatory Filings	2017-01-15	English
Biotron Presents at Biotech Showcase 2017 22 pages 3.6MB Regulatory Filings	2017-01-12	English
Corrected Presentation to Biotech Showcase 2017 26 pages 3.8MB Regulatory Filings	2017-01-12	English

Filings by year

2026 12 filings
2025 82 filings
2024 35 filings
2023 32 filings
2022 38 filings
2021 22 filings
2020 30 filings
2019 38 filings
2018 61 filings
2017 37 filings
2016 26 filings
2015 32 filings
2014 33 filings
2013 27 filings
2012 28 filings
2011 41 filings
2010 29 filings
2009 26 filings
2008 17 filings
2007 25 filings
2006 26 filings
2005 21 filings
2004 24 filings
2003 20 filings
2002 2 filings